SCHEMBL2188153

SCHEMBL2188153

CC(C)(C)N(CCCCCNC(=O)c1csc(CNC(=O)COc2ccc(OC(F)(F)F)cc2)n1)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 5/20 0.40
HDAC1 Q13547 5/20 0.40
HDAC6 Q9UBN7 5/20 0.40
MCHR1 Q99705 5/20 0.38
HTR2C P28335 1/20 0.38
MCHR2 Q969V1 1/20 0.38
HDAC4 P56524 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC10 Q969S8 2/20 0.37
HDAC11 Q96DB2 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
HDAC9 Q9UKV0 2/20 0.37
HDAC5 Q9UQL6 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5669715 0.85 HDAC3 (0.43) HDAC3HDAC1HDAC6MCHR1HDAC4
SCHEMBL5667971 0.84 HDAC3 (0.41) HDAC3HDAC1HDAC6HDAC4HDAC7
SCHEMBL5667723 0.84 ABL1 (0.44) HDAC3HDAC1HDAC6MEN1KMT2A
SCHEMBL5669968 0.83 CYP1A2 (0.41) HDAC3HDAC1HDAC6MCHR1HDAC4
SCHEMBL4389889 0.82 TSHR (0.50) HDAC3HDAC1HDAC6HDAC2MEN1
SCHEMBL4389229 0.81 CYP1A2 (0.40) HDAC3HDAC1HDAC6MCHR1HDAC4
SCHEMBL5667982 0.81 KDM4E (0.47) MEN1KMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL2172869 0.79 CYP1A2 (0.43) MEN1KMT2ACYP1A2POLBCYP3A4
SCHEMBL4388201 0.79 CYP1A2 (0.39) HDAC3HDAC1HDAC6MCHR1HDAC4
SCHEMBL2173905 0.79 SHMT2 (0.43) HDAC3HDAC1HDAC6MCHR1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973061-B2 Anaplastic lymphoma kinase modulators and methods of use EXELIXIS, INC. (US) 2011-07-05 US disclosed